73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Cellular 'waste product' rejuvenates cancer-fighting immune cells

Cellular 'waste product' rejuvenates cancer-fighting immune cells

byUT Southwestern Medical CenterUT Southwestern Simmons Cancer Center found that lactate, a metabolic byproduct produced by cells during strenuous exercise, can rejuvenate immune cells that figh

Cellular 'waste product' rejuvenates cancer-fighting immune cells

byUT Southwestern Medical CenterUT Southwestern Simmons Cancer Center found that lactate, a metabolic byproduct produced by cells during strenuous exercise, can rejuvenate immune cells that figh
How air pollution can cause lung cancer in non-smokers

How air pollution can cause lung cancer in non-smokers

byUniversity College LondonCredit: CC0 Public DomainA new study led by researchers at UCL and the Francis Crick Institute has demonstrated for the first time how air pollution can cause lung can

How air pollution can cause lung cancer in non-smokers

byUniversity College LondonCredit: CC0 Public DomainA new study led by researchers at UCL and the Francis Crick Institute has demonstrated for the first time how air pollution can cause lung can
Blood Thinners: What You Should Know

Blood Thinners: What You Should Know

Blood Thinners: What You Should KnowByAngela Ryan Lee, MDPublished on January 24, 2022Medically reviewed byAnisha Shah, MDBlood thinners are medications used to treat and

Blood Thinners: What You Should Know

Blood Thinners: What You Should KnowByAngela Ryan Lee, MDPublished on January 24, 2022Medically reviewed byAnisha Shah, MDBlood thinners are medications used to treat and
Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient

Combined MET and PD-L1 inhibition shows promise in MET-driven metastatic papillary renal cancer

by Vall d'Hebron Institute of OncologyCredit: Pixabay/CC0 Public DomainAdvanced papillary renal cancer (PRC) has a poor prognosis with few treatment options available. Approximately 30% of patient
Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs

Study: Tumor necroptosis promotes metastasis by modulating tumor-host immunity

by Impact Journals LLCTumor necroptosis promotes metastasis of breast cancer by suppressing anti-tumor immunity. Credit: 2023 Liu et al.A new editorial paper was published inOncotarget's&nbs
Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res

Drug that targets scar-like tissue in tumors shows promise for aggressive pancreatic cancer

by Garvan Institute of Medical ResearchThe new drug, PXS-5505, breaking down the fibrotic tissue around pancreatic cancer cells. Credit: Ella MaruFindings from the Garvan Institute of Medical Res
Researchers design multiclass cancer diagnostic tool using AI and miRNA

Researchers design multiclass cancer diagnostic tool using AI and miRNA

by Florida Atlantic UniversityCancers originating from different primary sample sites have specific patterns of miRNA expression, as revealed by principal component analysis, a popular technique

Researchers design multiclass cancer diagnostic tool using AI and miRNA

by Florida Atlantic UniversityCancers originating from different primary sample sites have specific patterns of miRNA expression, as revealed by principal component analysis, a popular technique
Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in

Lazarus effect in a patient treated with osimertinib for non-small cell lung cancer with leptomeningeal disease

by Impact Journals LLCTreatment timeline with chest computed tomography (CT) and brain magnetic resonance images (MRI) on osimertinib. (A) Pretreatment CT chest, demonstrating 18 mm spiculated mass in
Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of
New genetic culprit suspected in the onset of pancreatic cancer

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat
Study shows no mitotane needed for patients with low risk of recurrence of adrenocortical carcinoma

Study shows no mitotane needed for patients with low risk of recurrence of adrenocortical carcinoma

by Universitätsklinikum WürzburgAdrenocortical carcinoma is a malignant degeneration of one of the hormone glands, which sit in pairs as small caps on the kidney. Credit: Nuclear Medicine University H

Study shows no mitotane needed for patients with low risk of recurrence of adrenocortical carcinoma

by Universitätsklinikum WürzburgAdrenocortical carcinoma is a malignant degeneration of one of the hormone glands, which sit in pairs as small caps on the kidney. Credit: Nuclear Medicine University H